Quantcast
Last updated on April 18, 2014 at 5:30 EDT

STAAR Surgical Announces Fourth Quarter 2011 Results Release Date and Conference Call and Webcast

February 13, 2012

MONROVIA, Calif., Feb. 13, 2012 /PRNewswire/ — STAAR Surgical Company (NASDAQ: STAA) today announced that it will release its financial results for the fourth quarter ended December 31, 2011 on Tuesday, March 6, 2012 after the market close. The Company will host a conference call and webcast on Tuesday, March 6, 2012 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss the Company’s fourth quarter and full year 2011 results and recent corporate developments. The dial-in number for the conference call is 877-941-8609 for domestic participants and 480-629-9692 for international participants.

The Company will also be using slides to illustrate its fourth quarter and full year 2011 results and operational progress. The slides and live webcast of the call can be accessed from the investor relations section of the STAAR website at www.staar.com.

A taped replay of the conference call will also be available beginning approximately one hour after the call’s conclusion and will be available for seven days. This replay can be accessed by dialing 800-406-7325 for domestic callers and 303-590-3030 for international callers, both using passcode 4511536#. An archived webcast will also be available at www.staar.com.

About STAAR Surgical

STAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR’s lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or “ICL.” A lens used to replace the natural lens after cataract surgery is called an intraocular lens or “IOL.” Over 250,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: www.visianinfo.com. STAAR has approximately 300 full time employees and markets lenses in approximately 50 countries. Headquartered in Monrovia, CA, it manufactures in the following locations: Nidau, Switzerland; Ichikawa City, Japan; Aliso Viejo, CA; and Monrovia, CA. For more information, please visit the Company’s website at www.staar.com or call 626-303-7902.

Collamer® is the registered trademark for STAAR’s proprietary biocompatible collagen copolymer lens material.

    CONTACT:                      Investors                  Media
                                  EVC Group                  EVC Group
                                  Jenifer Kirtland           Chris Gale
                                  Doug Sherk                 646-201-5431
                                  415-568-4887

SOURCE STAAR Surgical Company


Source: PR Newswire